Double-Well Potential : The WKB Approximation with Phase Loss and Anharmonicity Effect

We derive a general WKB energy splitting formula in a double-well potential by incorporating both phase loss and anharmonicity effect in the usual WKB approximation. A bare application of the phase loss approach to the usual WKB method gives better results only for large separation between two potential minima. In the range of substantial tunneling, however, the phase loss approach with anharmonicity effect considered leads to a great improvement on the accuracy of the WKB approximation.Comment: 14 pages, revtex, 1 figure, will appear at Phys. Rev.

Charge states and magnetic ordering in LaMnO3/SrTiO3 superlattices

We investigated the magnetic and optical properties of [(LaMnO3)n/(SrTiO3)8]20 (n = 1, 2, and 8) superlattices grown by pulsed laser deposition. We found a weak ferromagnetic and semiconducting state developed in all superlattices. An analysis of the optical conductivity showed that the LaMnO3 layers in the superlattices were slightly doped. The amount of doping was almost identical regardless of the LaMnO3 layer thickness up to eight unit cells, suggesting that the effect is not limited to the interface. On the other hand, the magnetic ordering became less stable as the LaMnO3 layer thickness decreased, probably due to a dimensional effect.Comment: 17 pages including 4 figures, accepted for publication in Phys. Rev.

Characteristics of gate-all-around silicon nanowire field effect transistors with asymmetric channel width and source/drain doping concentration

We performed 3D simulations to demonstrate structural effects in sub-20 nm gate-all-around silicon nanowire field effect transistors having asymmetric channel width along the channel direction. We analyzed the differences in the electrical and physical properties for various slopes of the channel width in asymmetric silicon nanowire field effect transistors (SNWFETs) and compared them to symmetrical SNWFETs with uniform channel width. In the same manner, the effects of the individual doping concentration at the source and drain also have been investigated. For various structural conditions, the current and switching characteristics are seriously affected. The differences attributed to the doping levels and geometric conditions are due to the electric field and electron density profile. (C) 2012 American Institute of Physics. [http://dx.doi.org/10.1063/1.4745858]ope

Aging Logarithmic Conformal Field Theory : a holographic view

We consider logarithmic extensions of the correlation and response functions of scalar operators for the systems with aging as well as Schr\"odinger symmetry. Aging is known to be the simplest nonequilibrium phenomena, and its physical significances can be understood by the two-time correlation and response functions. Their logarithmic part is completely fixed by the bulk geometry in terms of the conformal weight of the dual operator and the dual particle number. Motivated by recent experimental realizations of Kardar-Parisi-Zhang universality class in growth phenomena and its subsequent theoretical extension to aging, we investigate our two-time correlation functions out of equilibrium, which show several qualitatively different behaviors depending on the parameters in our theory. They exhibit either growing or aging, i.e. power-law decaying, behaviors for the entire range of our scaling time. Surprisingly, for some parameter ranges, they exhibit growing at early times as well as aging at later times.Comment: 1+26 pages, 15 figure

Noncritical Einstein-Weyl Gravity and the AdS/CFT Correspondence

We explore four-dimensional Einstein-Weyl gravity and supergravity on anti-de Sitter spacetime. For a specific range of the coupling with appropriate boundary conditions, we show the effective equivalence of the theory with Einstein gravity and AdS supergravity at the quadratic Lagrangian level. Furthermore we show that these equivalences can be promoted to the full nonlinear level. We also show that the similar behavior holds for the generalized Gibbons-Hawking terms. From this we find that the correlation functions in the dual conformal field theory of Einstein-Weyl gravity and supergravity can be readily read off from corresponding ones from Einstein gravity and AdS supergravity. We also give comments on some issues in critical gravity and supergravity as well as conformal gravity and supergravity.Comment: 20 pages, 1 figure: v2, references and footnote added, typos correcte

The 'Harmonizing Optimal Strategy for Treatment of coronary artery stenosis - sAfety & effectiveneSS of drug-elUting stents & antiplatelet REgimen' (HOST-ASSURE) trial: study protocol for a randomized controlled trial

<p>Abstract</p> <p>Background</p> <p>Second-generation drug-eluting stents (DES) have raised the bar of clinical performance. These stents are mostly made from cobalt chromium alloy. A newer generation DES has been developed from platinum chromium alloy, but clinical data regarding the efficacy and safety of the platinum chromium-based everolimus-eluting stent (PtCr-EES) is limited, with no comparison data against the cobalt chromium-based zotarolimus-eluting stent (CoCr-ZES). In addition, an antiplatelet regimen is an integral component of medical therapy after percutaneous coronary intervention (PCI). A 1-week duration of doubling the dose of clopidogrel (double-dose antiplatelet therapy (DDAT)) was shown to improve outcome at 1 month compared with conventional dose in acute coronary syndrome (ACS) patients undergoing PCI. However in Asia, including Korea, the addition of cilostazol (triplet antiplatelet therapy (TAT)) is used more commonly than doubling the dose of clopidogrel in high-risk patients.</p> <p>Methods</p> <p>In the 'Harmonizing Optimal Strategy for Treatment of coronary artery stenosis - sAfety & effectiveneSS of drug-elUting stents & antiplatelet REgimen' (HOST-ASSURE) trial, approximately 3,750 patients are being prospectively and randomly assigned in a 2 × 2 factorial design according to the type of stent (PtCr-EES vs CoCr-ZES) and antiplatelet regimen (TAT vs DDAT). The first primary endpoint is target lesion failure at 1 year for the stent comparison, and the second primary endpoint is net clinical outcome at 1 month for comparison of antiplatelet therapy regimen.</p> <p>Discussion</p> <p>The HOST-ASSURE trial is the largest study yet performed to directly compare the efficacy and safety of the PtCr-EES versus CoCr-ZES in an 'all-comers' population. In addition, this study will also compare the clinical outcome of TAT versus DDAT for 1-month post PCI.</p> <p>Trial registration</p> <p>ClincalTrials.gov number <a href="http://www.clinicaltrials.gov/ct2/show/NCT01267734">NCT01267734</a>.</p

Does Glycine max leaves or Garcinia Cambogia promote weight-loss or lower plasma cholesterol in overweight individuals: a randomized control trial

<p>Abstract</p> <p>Background</p> <p>Natural food supplements with high flavonoid content are often claimed to promote weight-loss and lower plasma cholesterol in animal studies, but human studies have been more equivocal. The aim of this study was firstly to determine the effectiveness of natural food supplements containing <it>Glycine max </it>leaves extract (EGML) or <it>Garcinia cambogia </it>extract (GCE) to promote weight-loss and lower plasma cholesterol. Secondly to examine whether these supplements have any beneficial effect on lipid, adipocytokine or antioxidant profiles.</p> <p>Methods</p> <p>Eighty-six overweight subjects (Male:Female = 46:40, age: 20~50 yr, BMI > 23 < 29) were randomly assigned to three groups and administered tablets containing EGML (2 g/day), GCE (2 g/day) or placebo (starch, 2 g/day) for 10 weeks. At baseline and after 10 weeks, body composition, plasma cholesterol and diet were assessed. Blood analysis was also conducted to examine plasma lipoproteins, triglycerides, adipocytokines and antioxidants.</p> <p>Results</p> <p>EGML and GCE supplementation failed to promote weight-loss or any clinically significant change in %body fat. The EGML group had lower total cholesterol after 10 weeks compared to the placebo group (p < 0.05). EGML and GCE had no effect on triglycerides, non-HDL-C, adipocytokines or antioxidants when compared to placebo supplementation. However, HDL-C was higher in the EGML group (p < 0.001) after 10 weeks compared to the placebo group.</p> <p>Conclusions</p> <p>Ten weeks of EGML or GCE supplementation did not promote weight-loss or lower total cholesterol in overweight individuals consuming their habitual diet. Although, EGML did increase plasma HDL-C levels which is associated with a lower risk of atherosclerosis.</p